Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study.
about
Long-term pharmacotherapy for obesity and overweightAntidepressants and cardiovascular adverse events: A narrative reviewAssociation of CYP2B6, CYP3A5, and CYP2C19 Genetic Polymorphisms With Sibutramine Pharmacokinetics in Healthy Korean SubjectsNorepinephrine transport inhibition for treatment of vasovagal syncope.The effectiveness of pharmaceutical interventions for obesity: weight loss with orlistat and sibutramine in a United Kingdom population-based cohort.Serotonin and blood pressure regulation.Safety assessment of an anti-obesity drug (sibutramine): a retrospective cohort study.
P2860
Q24247723-96ADA9DD-F1D9-4CB0-B820-7E901259AF8EQ26771629-440600F3-2F5D-4861-A63F-6CB04FCEA9F8Q29308187-6487EC3B-A7D4-4DCA-9BA3-5F8167AA07F2Q33162426-38BB5245-C00E-4AC2-B0C0-FF1A3C79C157Q35684845-DC7C5BA9-B20B-4CD4-9D0C-D528FD3A52BDQ35847080-CC772F79-6A63-4ED1-922E-3C46808CFBC9Q47392852-7A92F3FE-B401-483D-9F6B-F2EB058F84D5
P2860
Efficacy and safety of sibutramine in 2225 subjects with cardiovascular risk factors: short-term, open-label, observational study.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Efficacy and safety of sibutra ...... en-label, observational study.
@en
Efficacy and safety of sibutra ...... en-label, observational study.
@nl
type
label
Efficacy and safety of sibutra ...... en-label, observational study.
@en
Efficacy and safety of sibutra ...... en-label, observational study.
@nl
prefLabel
Efficacy and safety of sibutra ...... en-label, observational study.
@en
Efficacy and safety of sibutra ...... en-label, observational study.
@nl
P2860
P356
P1476
Efficacy and safety of sibutra ...... en-label, observational study.
@en
P2093
P2860
P2888
P304
P356
10.1038/SJ.JHH.1001877
P577
2005-09-01T00:00:00Z
P5875
P6179
1047187129